HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 204 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $106,000 | +37.7% | 5,949 | +20.4% | 0.00% | 0.0% |
Q3 2019 | $77,000 | -7.2% | 4,939 | +2.9% | 0.00% | 0.0% |
Q2 2019 | $83,000 | +33.9% | 4,800 | +25.2% | 0.00% | – |
Q1 2019 | $62,000 | +10.7% | 3,833 | -0.8% | 0.00% | -100.0% |
Q4 2018 | $56,000 | -15.2% | 3,862 | +5.7% | 0.00% | 0.0% |
Q3 2018 | $66,000 | +500.0% | 3,653 | +548.8% | 0.00% | – |
Q2 2018 | $11,000 | 0.0% | 563 | 0.0% | 0.00% | – |
Q1 2018 | $11,000 | +10.0% | 563 | +9.5% | 0.00% | – |
Q4 2017 | $10,000 | +42.9% | 514 | +24.2% | 0.00% | – |
Q3 2017 | $7,000 | +250.0% | 414 | +94.4% | 0.00% | – |
Q2 2017 | $2,000 | +100.0% | 213 | +113.0% | 0.00% | – |
Q1 2017 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q4 2016 | $1,000 | -98.1% | 100 | -97.7% | 0.00% | -100.0% |
Q3 2016 | $52,000 | +48.6% | 4,300 | +7.5% | 0.00% | 0.0% |
Q2 2016 | $35,000 | -7.9% | 4,000 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $38,000 | -44.9% | 4,000 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $69,000 | -1.4% | 4,000 | -23.1% | 0.00% | 0.0% |
Q3 2015 | $70,000 | -9.1% | 5,200 | +52.9% | 0.00% | 0.0% |
Q2 2015 | $77,000 | +57.1% | 3,400 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $49,000 | +48.5% | 3,400 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $33,000 | +200.0% | 3,400 | +183.3% | 0.00% | – |
Q3 2014 | $11,000 | +450.0% | 1,200 | +500.0% | 0.00% | – |
Q2 2014 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | – |
Q1 2014 | $3,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |